Skip to main content
. 2006 Oct;146(1):9–14. doi: 10.1111/j.1365-2249.2006.03178.x

Fig. 3.

Fig. 3

Longitudinal analysis of insulin binding antibodies in samples taken at clinical diagnosis and the indicated time-points. Samples of the 0–18-year-old patient group (1) and the 15–34-year-old patient group (2) were analysed for their binding to [125]I-insulin in the presence of recombinant Fab (rFab) AE9D6 (a) and CG7C7 (b). Binding is reported as percentage in comparison to uncompeted binding (set as 100%) and plotted against time after clinical onset of type 1 diabetes (T1D) (months).